A 2022 dose-response RCT (Yi et al., Geroscience) at 300/600/900 mg/day raised NAD+ dose-dependently with no safety issues at 60 days
legal to buy for research purposes only. UK & EU: Classified as unlicensed medicinesillegal to market for human consumption
C195015021), 2017 Elite Talents Training Plan of the Third Affiliated Hospital of Guangzhou Medical University (J.P.), and Special Funds for the Cultivation of Guangdong College Students Scientific and Technological Innovation: Climbing Program Special Funds (No
The best studied is GHK-Cu, the tripeptide glycyl-L-histidyl-L-lysine complexed with copper
The outcome of this study, following the delivery of the cell culture with Epithalon, was that the peptide appeared to induce activation of the ribosomal genes and decondensation of the heterochromatin
Pharmaceuticals , 18(2), 185